Malignant neoplasm of short bones of right lower limb
- C40.31 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
- The 2024 edition of ICD-10-CM C40.31 became effective on October 1, 2023.
- This is the American ICD-10-CM version of C40.31 – other international versions of ICD-10 C40.31 may differ.
The following code(s) above C40.31 contain annotation back-references
that may be applicable to C40.31:
- C00-D49 Neoplasms
- C40-C41 Malignant neoplasms of bone and articular cartilage
- C40 Malignant neoplasm of bone and articular cartilage of limbs
Approximate Synonyms
- Bone cancer, bilateral feet
- Bone cancer, right foot
- Chondrosarcoma, bilateral feet
- Chondrosarcoma, right foot
- Ewings sarcoma, bilateral feet
- Ewings sarcoma, right foot
- Osteosarcoma, bilateral feet
- Osteosarcoma, right foot
- Primary chondrosarcoma of bilateral feet
- Primary chondrosarcoma of right foot
- Primary ewing’s sarcoma of bilateral feet
- Primary ewing’s sarcoma of right foot
- Primary malignant neoplasm of bone of bilateral feet
- Primary malignant neoplasm of bone of right foot
- Primary osteosarcoma of bilateral feet
- Primary osteosarcoma of right foot
ICD-10-CM C40.31 is grouped within Diagnostic Related Group(s) (MS-DRG v41.0):
- 542 Pathological fractures and musculoskeletal and connective tissue malignancy with mcc
- 543 Pathological fractures and musculoskeletal and connective tissue malignancy with cc
- 544 Pathological fractures and musculoskeletal and connective tissue malignancy without cc/mcc
Convert C40.31 to ICD-9-CMCode History
- 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
- 2017 (effective 10/1/2016): No change
- 2018 (effective 10/1/2017): No change
- 2019 (effective 10/1/2018): No change
- 2020 (effective 10/1/2019): No change
- 2021 (effective 10/1/2020): No change
- 2022 (effective 10/1/2021): No change
- 2023 (effective 10/1/2022): No change
- 2024 (effective 10/1/2023): No change